

Explore by topic
2026 (first half) — Strong results, continued capital returns
Munich Re reported solid half-year 2026 results and continued returning capital via dividend policy and buybacks announced earlier. The AGM on 29 April 2026 approved a €24.00 per-share dividend for the 2025 business year. Market narrative emphasized resilient underwriting and investment performance after several years of above-target profits. Investor focus shifted to shareholder returns and capital management as evidence of sustained cash generation.
Key metrics: Dividend per share for 2025: €24.00 per share (AGM approval 29 April 2026) [1][3].
2025 — Record dividend and continued profitability
Munich Re maintained high profitability in 2025 and the company's AGM approved the elevated dividend level. Investors treated Munich Re increasingly as a dividend compounder with strong capital discipline after a sequence of above-target net results. The stronger dividend supported total-return arguments despite cyclical nat-cat risk.
Key metrics: Dividend per share for 2025: €24.00 per share; dividend yield (relation to 2025 year-end share price): 4.3% [1][3].
2024 — Record net result and outperformance versus targets
Munich Re reported a consolidated net result of €5.7 billion for 2024 and highlighted outperformance versus internal targets. The Group Annual Report 2024 documents record results in life reinsurance and a total technical result beat in some segments. The company's narrative evolved to "outperformance and resilience" after exceeding targets for multiple years. Investor perception improved as Munich Re demonstrated both underwriting strength and favourable investment income in a challenging macro backdrop.
Key metrics: Consolidated net result (2024): €5,671 million; total technical result improvements cited in annual report (life reinsurance record) [4][11].
2023 — Strong profit, larger buyback and dividend increase
Munich Re reported a net result of €4.6 billion for 2023, announced a significant dividend increase to €15.00 per share (subject to AGM approval) and approved a new €1.5 billion share buy-back programme. After exceptional results, investor sentiment turned toward capital returns and recognition that the business had navigated 2022–2023 shocks (inflation, war, nat-cat) while maintaining profitability. The combination of dividends and buybacks reinforced the shareholder-friendly view.
Key metrics: Net result (2023): €4.6 billion; dividend per share proposed for 2023: €15.00; new share buy-back: €1.5 billion [5][7].
2022 — Post-pandemic/war/inflation shock period; resilience highlighted
Munich Re disclosed that 2022 had been a challenging year with major losses from natural catastrophes and the macro environment affected by inflation and the war in Ukraine. Nevertheless the company reported it remained financially robust. Investor perception shifted from short-term shock concerns to cautious confidence in the balance sheet. Munich Re's messaging emphasised capital strength and ability to withstand elevated insured losses and geopolitical/inflationary stress.
Key metrics: Management described the 2022 environment as featuring high natural catastrophe losses and macro headwinds; company commentary at 2023 AGM referenced the balance sheet withstanding 2022 challenges [12][10].
2021 — Recovery phase and focus on underwriting discipline
Munich Re entered the 2021–2022 period focusing on underwriting discipline and renewal pricing in property-casualty and reinsurance after nat-cat heavy years. Annual and solvency disclosures in 2021–2022 set the stage for subsequent margin recovery. Investors began to revalue Munich Re toward a recovery/quality insurer story, expecting pricing and underwriting improvements to translate into better technical results. The company was portrayed as moving from cyclical stress toward stabilization.
Key metrics: Regulatory and solvency disclosures and segment commentary from the 2021–2022 reporting cycle underpinned expectations for improved technical results [10][12].
Munich Re (Münchener Rück) operates as a global reinsurance leader in a competitive landscape defined by large diversified reinsurers and well-capitalized insurance groups. Its primary competitors are global reinsurers with overlapping exposure across property-casualty, life and health, and specialty lines, alongside marketplace participants such as Lloyd's syndicates. The company faces material risks from catastrophic loss volatility, capital and liquidity strain during significant events, competition from alternative capital sources, regulatory and macroeconomic changes, and operational challenges spanning technology, climate modeling, and model risk more broadly.
Munich Re (MUV2.XETRA, ISIN DE0008430026) operates as a global reinsurer with meaningful primary-insurance operations through its ERGO subsidiary. Its competitive set consists of other large global reinsurers and diversified insurance groups active in property-casualty, life & health, and specialty underwriting. Competition turns on scale, capital strength, catastrophe modelling capability, and specialty underwriting expertise. The business faces material risks from underwriting losses triggered by large catastrophe events, market and investment volatility that can strain reserves and capital adequacy, regulatory and solvency requirement changes across different jurisdictions, and pricing and terms pressure from other well-capitalized competitors and alternative capital sources.
| Company | Ticker |
|---|---|
| SCOR SE | SCR.PA |
| Berkshire Hathaway Inc. | BRK-B.NYSE |
| RenaissanceRe Holdings Ltd. | RNR.NYSE |
| Everest Re Group, Ltd. | RE.NYSE |
| PartnerRe Ltd. | PRE.NYSE |
| Reinsurance Group of America, Inc. | RGA.NYSE |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial| Period | Münchener Rück AG | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | -0.19% | +3.14% | -1.60% |
| 3M | +2.44% | +2.35% | -1.46% |
| 6M | -2.36% | -7.98% | -17.60% |
| 1Y | -5.42% | -8.52% | -23.11% |
| 3Y | +53.41% | -11.67% | -34.67% |
| 5Y | +156.68% | +91.34% | +66.44% |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHow the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 9.4 | 0.9 | 1.9 | 51.1 |
| 1Y ago | 11.9 | 1.2 | 2.4 | 23.3 |
| 3Y ago | 9.9 | 0.8 | 1.9 | -6.7 |
| 5Y ago | 14.8 | 0.5 | 1.1 | 4.7 |
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 24.00 EUR | 4.56% | 4.24% |
| 2025 | 20.00 EUR | 3.32% | |
| 2024 | 15.00 EUR | 3.54% | |
| 2023 | 11.60 EUR | 3.43% | |
| 2022 | 11.00 EUR | 4.56% | |
| 2021 | 9.80 EUR | 3.81% | |
| 2020 | 9.80 EUR | 4.44% | |
| 2019 | 9.25 EUR | 4.15% | |
| 2018 | 8.60 EUR | 4.35% | |
| 2017 | 8.60 EUR | 4.54% | |
| 2016 | 8.25 EUR | 4.74% | |
| 2015 | 7.75 EUR | 4.06% | |
| 2014 | 7.25 EUR | 4.36% | |
| 2013 | 7.00 EUR | 4.41% | |
| 2012 | 6.25 EUR | 5.34% |
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 69.30B | 69.11B | 70.46B | 64.11B | 63.86B |
| Operating income (EBIT) | 8.63B | 8.71B | 3.63B | 10.01B | 2.41B |
| Net income | 6.12B | 5.68B | 4.66B | 3.42B | 2.93B |
| Free cash flow | 1.10B | 2.83B | 2.40B | -7.64B | 5.23B |
| Total assets | 279.93B | 286.51B | 273.79B | 298.57B | 312.40B |
| Equity | 33.25B | 32.64B | 29.65B | 21.06B | 30.83B |
| Net debt | 1.93B | 205.00M | -3.86B | -2.87B | -1.98B |